ResMed Financial Ratios
NYSE: RMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ResMed ratio analysis
ResMed earned a net margin of 26.9% in FY 2026, down from 27.2% a year earlier. Gross margin was 61.1% compared with a median of 57.3% over the prior 9 years. Return on equity reached 23.1%, meaning ResMed generated 0.23 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.10 versus 0.11 the year before, and the current ratio was 3.10. At the end of FY 2026, RMD traded at 20.1 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 20.1 to 77.3, with a median of 38.3. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
ResMed financial ratios (annual)
| Ratio | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 20.10 | 27.02 | 27.66 | 35.88 | 40.70 | 77.32 | 45.08 | 43.58 | 47.30 | 32.45 |
| Price / sales | 5.40 | 7.33 | 6.01 | 7.59 | 8.81 | 11.39 | 9.40 | 6.70 | 6.32 | 5.33 |
| Price / book | 4.63 | 6.32 | 5.79 | 7.76 | 9.38 | 12.62 | 11.13 | 8.43 | 7.18 | 5.62 |
| Gross margin | 61.1% | 59.4% | 56.7% | 55.8% | 56.6% | 57.5% | 58.1% | 57.3% | 57.0% | 58.1% |
| Operating margin | 33.4% | 32.7% | 28.2% | 26.8% | 28.0% | 28.3% | 27.4% | 22.2% | 23.2% | 20.6% |
| Net margin | 26.9% | 27.2% | 21.8% | 21.3% | 21.8% | 14.8% | 21.0% | 15.5% | 13.5% | 16.6% |
| Free cash flow margin | 29.2% | 32.3% | 27.8% | 13.6% | 6.0% | 19.8% | 23.9% | 15.0% | 18.9% | 17.0% |
| Return on equity (ROE) | 23.1% | 23.5% | 21.0% | 21.7% | 23.2% | 16.4% | 24.9% | 19.5% | 15.3% | 17.5% |
| Return on assets (ROA) | 17.0% | 17.1% | 14.9% | 13.3% | 15.3% | 10.0% | 13.6% | 9.8% | 10.3% | 9.9% |
| Debt / equity | 0.10 | 0.11 | 0.15 | 0.35 | 0.23 | 0.23 | 0.47 | 0.61 | 0.14 | 0.55 |
| Current ratio | 3.10 | 3.44 | 2.59 | 3.12 | 2.80 | 1.73 | 2.53 | 2.06 | 2.08 | 4.57 |
| Revenue growth | 9.9% | 9.8% | 10.9% | 18.0% | 11.9% | 8.1% | 13.4% | 11.4% | 13.2% | 12.4% |
| EPS growth | 9.7% | 37.4% | 13.6% | 14.9% | 63.6% | -24.1% | 52.5% | 27.9% | -8.8% | -3.6% |